# Risk Analysis: RSK-FW-001

> **Risk ID**: `RSK-FW-001`  
> **Risk Control Measure ID**: `RCM-FW-001`  
> **Title**: Premature Phase Transition or Gate Review Bypass  
> **Standard Reference**: ISO 14971:2019 Clause 5.4, ISO 13485:2016 Clause 7.3.5  
> **Target Requirement**: `FR-ORCH-001`, `FR-ORCH-002`, `FR-SKILL-003`  
> **Allocated Architecture**: `docs/architecture/ARCH-FW-003.md`  
> **Allocated Detailed Design**: `docs/detailed_design/DDS-FW-002.md`  
> **Verification Test Protocol**: `docs/tests/TC-FR-ORCH-002.md`, `docs/tests/TC-FR-SKILL-003.md`  

---

## 1. Hazard, Sequence of Events & Hazardous Situation
- **Hazard**: Unchecked autonomous agent state progression.
- **Sequence of Events**:
  1. An automated agent attempts to proceed from Phase 4 (SRS) to Phase 7/8 (Design/Coding) without clinical stakeholder sign-off.
  2. Incomplete or clinically erroneous software requirements are treated as approved.
- **Hazardous Situation**: Architectural design and clinical algorithms are implemented against defective or unapproved medical requirements.
- **Harm**: Medical diagnostic software produces erroneous clinical outputs, potentially delaying critical patient triage or causing misdiagnosis. (Severity: S4 - Critical, Probability: P3 - Medium $\to$ **Initial Risk: High / Unacceptable**).

## 2. Risk Control Measure: RCM-FW-001
- **Control Measure Description**: The framework shall implement a mandatory **2-Tier Human-in-the-Loop (HITL) Gate Governance Engine**.
  - Tier 1 Major Gates (Gates 1, 3, 4, 5, 9, 10) unconditionally halt agent execution until explicit human confirmation (`APPROVE`) is recorded with reviewer name and ISO 8601 timestamp.
  - Autonomous self-approval by agents is strictly prohibited by state machine logic.
- **Control Type**: Inherent Software Design / Process Interlock (ISO 14971 Clause 7.1 a).

## 3. Residual Risk Evaluation
- **Residual Severity**: S4 (Critical clinical impact remains if an approved requirement is flawed).
- **Residual Probability**: P1 (Extremely unlikely due to mandatory human gate sign-off).
- **Residual Risk Level**: **Low / Acceptable (ALARP satisfied)**.
- **Verification Evidence**: `VERIF-FW-001`, `VERIF-FW-002` via `TC-FR-ORCH-001.md`, `TC-FR-ORCH-002.md`.
## 4. Evaluation of New Hazards Arising from Risk Control Measures (ISO 14971:2019 Cl 7.3 & IEC 62304 Cl 7.2.2)
- **Potential New Hazards Introduced**:
  - Reviewer starvation / workflow deadlock: Human reviewer unavailability could block critical SaMD development pipeline indefinitely.
  - Review fatigue leading to rubber-stamping: Frequent gate stops could induce human operator fatigue, diminishing review vigilance.
- **Secondary Risk Mitigations**:
  - Asynchronous persistent state serialization (`DDS-FW-002`) allowing pipeline suspension and clean resumption without data loss or memory leaks.
  - 2-Tier gating classification ensuring only major safety/regulatory transitions (Tier 1) require explicit interactive sign-off, while routine intra-phase steps proceed automatically.
  - Mandatory audit trail logging of reviewer identity and timestamps preventing automated bot approvals.
- **Residual Risk Conclusion**: No unacceptable secondary hazards introduced. Residual risk remains **Acceptable (ALARP satisfied)**.
